Zenarestat -: Treatment of diabetic neuropathy aldose reductase inhibitor

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：104 / 105
页数：2
相关论文
共 50 条
  • [31] POLYOL PATHWAY AND DIABETIC NEUROPATHY - SELECTIVE PREVENTIVE EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR IN EXPERIMENTAL DIABETIC NEUROPATHY
    KAMIJO, M
    YAGIHASHI, S
    JAPANESE JOURNAL OF MEDICINE, 1991, 30 (06) : 629 - 630
  • [32] THE ROLE OF ALDOSE REDUCTASE INHIBITORS IN THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY
    YUE, DK
    BROOKS, B
    MEDICAL JOURNAL OF AUSTRALIA, 1993, 159 (02) : 76 - 78
  • [33] THE ROLE OF ALDOSE REDUCTASE INHIBITORS IN THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY
    FLORKOWSKI, CM
    MEDICAL JOURNAL OF AUSTRALIA, 1993, 159 (10) : 711 - 712
  • [34] TREATMENT OF DIABETIC POLYNEUROPATHY WITH TOLRESTAT, AN ALDOSE REDUCTASE INHIBITOR
    GUILLEN, MA
    DELAVEGA, MS
    ZORRILLA, E
    HERNANDEZ, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (04): : 455 - 467
  • [35] Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review
    Schemmel, Kate E.
    Padiyara, Rosalyn S.
    D'Souza, Jennifer J.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2010, 24 (05) : 354 - 360
  • [36] ABSORPTION, DISTRIBUTION AND EXCRETION OF ZENARESTAT, A NEW ALDOSE REDUCTASE INHIBITOR, IN RATS AND DOGS
    TANAKA, Y
    SEKIGUCHI, M
    SAWAMOTO, T
    KATAMI, Y
    UEDA, T
    ESUMI, Y
    NODA, K
    XENOBIOTICA, 1992, 22 (01) : 57 - 64
  • [37] Cardiac abnormalities in diabetic patients with neuropathy - Effects of aldose reductase inhibitor administration
    Johnson, BF
    Nesto, RW
    Pfeifer, MA
    Slater, WR
    Vinik, AI
    Chyun, DA
    Law, G
    Wackers, FJT
    Young, LH
    DIABETES CARE, 2004, 27 (02) : 448 - 454
  • [38] EFFECT OF A NEW POTENT ALDOSE REDUCTASE INHIBITOR, TAT ON DIABETIC NEUROPATHY OF RATS
    HOTTA, N
    KAKUTA, H
    KOH, N
    SAKAKIBARA, F
    KOMORI, H
    INUKAI, S
    NAITO, S
    SAKAMOTO, N
    DIABETOLOGIA, 1992, 35 : A151 - A151
  • [39] CLINICAL AND NEUROPHYSIOLOGICAL STUDIES WITH THE ALDOSE REDUCTASE INHIBITOR, SORBINIL, IN SYMPTOMATIC DIABETIC NEUROPATHY
    LEWIN, IG
    OBRIEN, IAD
    MORGAN, MH
    CORRALL, RJM
    DIABETOLOGIA, 1984, 26 (06) : 445 - 448
  • [40] EFFECT OF AN ALDOSE REDUCTASE INHIBITOR ON DIABETIC PERIPHERAL NEUROPATHY - PRELIMINARY-REPORT
    CULEBRAS, A
    ALIO, J
    HERRERA, JL
    LOPEZFRAILE, IP
    ARCHIVES OF NEUROLOGY, 1981, 38 (02) : 133 - 134
12345